C
Christopher J Malkin
Researcher at Leeds Teaching Hospitals NHS Trust
Publications - 30
Citations - 974
Christopher J Malkin is an academic researcher from Leeds Teaching Hospitals NHS Trust. The author has contributed to research in topics: Percutaneous coronary intervention & Aortic valve replacement. The author has an hindex of 12, co-authored 30 publications receiving 769 citations. Previous affiliations of Christopher J Malkin include Leeds General Infirmary & James Cook University Hospital.
Papers
More filters
Journal ArticleDOI
Long-Term Durability of Transcatheter Aortic Valve Prostheses
Daniel J. Blackman,Smriti Saraf,Philip MacCarthy,Aung Myat,Simon G. Anderson,Christopher J Malkin,Michael Cunnington,Kathryn Somers,Paul Brennan,Ganesh Manoharan,Jessica Parker,Omar Aldalati,Stephen Brecker,Cameron Dowling,Stephen P. Hoole,Stephen Dorman,Michael J. Mullen,Simon Kennon,Melanie Jerrum,Pavan Chandrala,David Roberts,Justin Tay,Sagar N. Doshi,Peter Ludman,Timothy A. Fairbairn,Joanne Crowe,Richard D. Levy,Adrian P. Banning,Neil Ruparelia,Mark S. Spence,David Hildick-Smith +30 more
TL;DR: In the authors' study, 91% of patients remained free of SVD between 5 and 10 years post-implantation, indicating long-term transcatheter aortic valve function is excellent.
Journal ArticleDOI
Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men
TL;DR: The protective effect of testosterone on myocardial ischaemia is maintained throughout treatment without decrement and the potentially beneficial effects of testosteroneOn body composition were confirmed and there were no adverse effects.
Journal ArticleDOI
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study.
Eberhard Grube,Nicolas M. van Mieghem,Sabine Bleiziffer,Thomas Modine,Johan Bosmans,Ganesh Manoharan,Axel Linke,Werner Scholtz,Didier Tchetche,Ariel Finkelstein,Ramiro Trillo,Claudia Fiorina,Antony Walton,Christopher J Malkin,Jae K. Oh,Hongyan Qiao,Stephan Windecker,Nicolas M. Van Mieghem,Ajay Sinhal,Robert Gooley,Tony Walton,Gerald Yong,John G. Webb,Michael W.A. Chu,Sam Radhakrishnan,Antonio Dager,Marian Branny,Emmanuel Teiger,Bernard Chevalier,Dominique Himbert,Gerhard Schymik,Tobias Zeus,Christoph J Jensen,Tienush Rassaf,Stephan Fichtlscherer,Georg Nickenig,Jörg Kempfert,Axel Harnath,Ruth H. Strasser,Christian Frerker,Konstantinos Spargias,Béla Merkely,Corrado Tamburino,Antonio Colombo,Anna Sonia Petronio,Francesco Bedogni,Giovanni Amoroso,Jan van der Heijden,Pim A.L. Tonino,Pedro Echeverria Beliz,Adam Witkowski,Vasco Gama Ribeiro,Moheeb Al Abdullah,Hellmuth Weich,José María Hernández García,César Morís,Anders Jönsson,Saib Khogali,David Hildick-Smith +58 more
TL;DR: TAVR using the next-generation THV is clinically safe and effective for treating older patients with severe AS at increased operative risk.
Journal ArticleDOI
Comparative Survival After Transapical, Direct Aortic, and Subclavian Transcatheter Aortic Valve Implantation (Data from the UK TAVI Registry)
Georg M. Fröhlich,Paul D. Baxter,Christopher J Malkin,D. Julian A. Scott,Neil Moat,David Hildick-Smith,David Cunningham,Philip MacCarthy,Uday Trivedi,Mark A. de Belder,Peter Ludman,Daniel J. Blackman +11 more
TL;DR: In this article, the authors compared outcomes of alternative non-femoral routes, transapical (TA), direct aortic (DA), and subclavian (SC), with standard femoral access.
Journal ArticleDOI
Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.
Peter McCartney,Hany Eteiba,Hany Eteiba,Annette Maznyczka,Annette Maznyczka,Margaret McEntegart,Margaret McEntegart,John P Greenwood,Douglas F Muir,Saqib Chowdhary,Anthony H. Gershlick,Clare Appleby,James Cotton,Andrew Wragg,Nick Curzen,Keith G. Oldroyd,Mitchell Lindsay,John Paul Rocchiccioli,Shaukat A,Richard Good,Stuart Watkins,Keith Robertson,Christopher J Malkin,Lynn Martin,Lynsey Gillespie,Thomas J. Ford,Mark C. Petrie,Mark C. Petrie,Peter W. Macfarlane,Tait Rc,Paul Welsh,Naveed Sattar,Robin A.P. Weir,Keith A.A. Fox,Ian Ford,Alex McConnachie,Colin Berry,Colin Berry +37 more
TL;DR: Among patients with acute STEMI presenting within 6 hours of symptoms, adjunctive low-dose intracoronary alteplase given during the primary percutaneous intervention did not reduce microvascular obstruction.